Immunoglobulin fragment F(ab’)(2) against RBD potently neutralizes SARS-CoV-2 in vitro

COVID-19, which is caused by the emerging human coronavirus SARS-CoV-2, has become a global pandemic that poses a serious threat to human health. To date, no vaccines or specific antiviral drugs have been approved for the treatment of this disease in clinic. Herein, therapeutic antibodies for SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xiaoyan, Zhou, Pengfei, Fan, Tiejiong, Wu, Yan, Zhang, Jing, Shi, Xiaoyue, Shang, Weijuan, Fang, Lijuan, Jiang, Xiaming, Shi, Jian, Sun, Yuan, Zhao, Shaojuan, Gong, Rui, Chen, Ze, Xiao, Gengfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351055/
https://www.ncbi.nlm.nih.gov/pubmed/32659292
http://dx.doi.org/10.1016/j.antiviral.2020.104868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351055/
https://www.ncbi.nlm.nih.gov/pubmed/32659292
http://dx.doi.org/10.1016/j.antiviral.2020.104868

Ejemplares similares